Outcomes of Neonatal Resuscitation
1 other identifier
observational
15,073
1 country
1
Brief Summary
The primary objective of this study is to describe mortality of newborns who received basic, advanced or no neonatal resuscitation immediately after birth at Shoklo Malaria Research Unit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 7, 2016
CompletedFirst Posted
Study publicly available on registry
July 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2016
CompletedOctober 6, 2017
October 1, 2017
5 months
June 7, 2016
October 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mortality 24 hours after birth of babies who received basic resuscitation
24 hours
Mortality 24 hours after birth of babies who received advanced resuscitation
24 hours
Mortality 24 hours after birth of babies who did not receive neonatal resuscitation
24 hours
Secondary Outcomes (11)
Mortality at 7 days
7 days
Mortality at 28 days
28 days
Mortality at one year
1 year
Proportion of live births requiring basic or advanced neonatal resuscitation.
24 hours
Number of newborns who received basic resuscitation, as a proportion of all live births.
24 hours
- +6 more secondary outcomes
Eligibility Criteria
All liveborn, singletons, ≥28 weeks gestation, birthed at SMRU, from 1 January 2008 to 31 December 2015 will be included.
You may qualify if:
- Liveborn singletons birthed at SMRU
- ≥28 weeks gestation
You may not qualify if:
- Stillborn infants
- Liveborn infants birthed at home or in the Thai hospital
- Major congenital abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shoklo Malaria Research Unit
Mae Sot, Changwat Tak, 63110, Thailand
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2016
First Posted
July 21, 2016
Study Start
April 1, 2016
Primary Completion
August 15, 2016
Study Completion
August 15, 2016
Last Updated
October 6, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will share